Nest Life Science Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 21-06-2024
- Paid Up Capital ₹ 5.00 M
as on 21-06-2024
- Company Age 14 Year, 7 Months
- Last Filing with ROC 31 Mar 2019
- Revenue -76.88%
(FY 2019)
- Profit -40.01%
(FY 2019)
- Ebitda 117.15%
(FY 2019)
- Net Worth 1.84%
(FY 2019)
- Total Assets -48.63%
(FY 2019)
About Nest Life Science
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Nirali Desai and Juhi Desai serve as directors at the Company.
- CIN/LLPIN
U24239GJ2010PTC060496
- Company No.
060496
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Apr 2010
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Nest Life Science Private Limited offer?
Nest Life Science Private Limited offers a wide range of products and services, including Ayurvedic Medicine, Herbal Medicine, Pharmaceutical Capsules, Softgel Capsules, Common Disease Medicines, Pharmaceutical Medicine, Pharma Ingredients & Raw Materials, Anti Infective API, Nutraceuticals & Dietary Supplements, Dietary Supplements.
Who are the key members and board of directors at Nest Life Science?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nirali Desai  | Additional Director | 07-May-2022 | Current |
| Juhi Desai | Director | 28-Jan-2019 | Current |
Financial Performance of Nest Life Science.
Nest Life Science Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 76.88% decrease. The company also saw a substantial fall in profitability, with a 40.01% decrease in profit. The company's net worth moved up by a moderate rise of 1.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nest Life Science?
In 2019, Nest Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Maruti Pharmachem Private LimitedActive 27 years 10 months
Nirali Desai and Juhi Desai are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nest Life Science?
Unlock and access historical data on people associated with Nest Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nest Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nest Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
